Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion type Assertion NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_head.
- NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion description "[Therefore, testing for KRAS and BRAF mutations could be a valuable adjunct in improving both prognosis and outcome stratification among patients with intrahepatic cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_provenance.
- NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion evidence source_evidence_literature NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_provenance.
- NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion SIO_000772 24139215 NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_provenance.
- NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion wasDerivedFrom befree-2016 NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_provenance.
- NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_assertion wasGeneratedBy ECO_0000203 NP1120658.RAKvI7XZAAPtFI7eczeqNKvOZ7sW1TlafjPQ8PMvVUFEQ130_provenance.